Rankings
▼
Calendar
CRON Q4 2025 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$983M
Q4 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$91M
+201.3% YoY
Gross Profit
$16M
17.7% margin
Operating Income
$7M
7.6% margin
Net Income
-$2M
-2.0% margin
EPS (Diluted)
$-0.00
QoQ Revenue Growth
+151.3%
Cash Flow
Operating Cash Flow
$12M
Free Cash Flow
$10M
Stock-Based Comp.
-$6M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$54M
Stockholders' Equity
$1.1B
Cash & Equivalents
$792M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$91M
$30M
+201.3%
Gross Profit
$16M
$11M
+49.8%
Operating Income
$7M
-$11M
+161.3%
Net Income
-$2M
$44M
-104.2%
Revenue Segments
Cannabis Flower
$34M
76%
Cannabis Extracts
$11M
24%
Product and Service, Other
$18,000
0%
Geographic Segments
CANADA
$28M
63%
ISRAEL
$12M
27%
Other Countries
$5M
11%
← FY 2025
All Quarters